RxDoctor Payments Data

Robert Paul, MD

Plastic and Reconstructive Surgery · Carmel, INNPI 1396903555

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Axogen at 26.7% of the total. 2025 is the largest year on record at $3,695, 6.8 times the $546 reported in 2019.

$6,279in general payments, 2019–2025

Across 37 payments — averaging $169.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$2K
  • Integra Lifesciences Corporation$2K
  • AbbVie$955
  • KCI USA, Inc.$944
  • TELA Bio, Inc.$465
  • Motiva USA, LLC$387
  • plus $351 from 6 others

What the payments were for

  • Consulting fees$2,35037%
  • Travel & lodging$1,03316%
  • Food & beverage$2,88546%
  • Education$100%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,279 in reported general payments places this provider in the 75th percentile of 47 plastic and reconstructive surgery providers in Indiana.

See all plastic and reconstructive surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$111,382
Medicare patients
110
Services billed
431

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen25$85
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$47
Oxycodone Hcl19$43

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →